Counterfeit Medicines
Counterfeit medicines: Guidance for pharmacists
The Royal Pharmaceutical Society of Great Britain (RPSGB) and the Medicines
and Healthcare products Regulatory Agency (MHRA) in May 2006 jointly published guidance for pharmacists
which explains the causes and consequences of counterfeiting and provides pharmacists with practical
advice on detecting and reporting suspected counterfeit medicines.
Counterfeit medicines: Guidance for pharmacists explains
the background to counterfeit medicine production and highlights how organised criminal gangs have become
involved in the production of illegal medicines and are supplying them through the internet, often to
unwitting patients. The guidance offers pharmacists invaluable practical advice on the correct
steps to take when they encounter suspected counterfeit medicines. These steps include reporting the
situation to the MHRA and ensuring immediate patient safety.
The guidance can be accessed at:
Northern Ireland
Any reports of suspected/actual counterfeit medicines in Northern Ireland
should be reported to:
Mr Martin McIlveen
Senior Investigation Officer
Department of Health Social Services and Public Safety
Pharmaceutical Advice and Services
Room 4.8
Castle Buildings
Stormont
Belfast
BT4 3SQ
Senior Investigation Officer
Department of Health Social Services and Public Safety
Pharmaceutical Advice and Services
Room 4.8
Castle Buildings
Stormont
Belfast
BT4 3SQ
E mail: Martin.McIlveen@dhsspsni.gov.uk
Tel: 028 9052 2094
January 2009
A hard-hitting cinema advert supported by the Medicines
and Healthcare products Regulatory Agency (MHRA), The Patients Association, Men’s Health Forum and H.E.A.R.T.
UK to warn about risks of fake medicine was launched in January 2009.
More
details can be accessed at:

